Vijay K Chopra

10PUBLICATIONS
77CO-AUTHORS
Respiratory diseasesEpidemiological modellingCardiology (incl. cardiovascular diseases)Pacific Peoples social determinants of health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 30, 2025
Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management.

Jabir Abdulakutty, Atul Abhyankar, Sandeep Seth

|Apr 06, 2024
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial.

Adrian F Hernandez, Jacob A Udell, W Schuyler Jones

|Dec 09, 2022
Patient-Reported Versus Physician-Assessed Health Status in Heart Failure With Reduced and Preserved Ejection Fraction From ASIAN-HF Registry.

Kanako Teramoto, Wan Ting Tay, Jasper Tromp

|Sep 13, 2022
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction.

Javed Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi

|Nov 15, 2021
Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.

Javed Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi

|Nov 08, 2021
Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial.

David D Berg, Kieran F Docherty, Naveed Sattar

Pageof 2

Frequent Collaborators

3 joint publications

Stefan D Anker

3 joint publications

Martina Brueckmann

3 joint publications

Piotr Ponikowski

3 joint publications

Javed Butler